• BDO
• 18 Nov, 2018

Race Against Patent Expirations Fuels Biotech R&D For biotech, the time for innovation has never been better. With more than 25 patent expirations on the horizon from 2018-19, an FDA focused on encouraging competition, and a charge to break down silos across counterparts in healthcare to drive more precise, improved outcomes and shared value, research and development (R&D) in the industry is booming.
Read more...